TP53 and neoplasm: The authors had previously shown that mutant p53 increases tumor invasiveness in a cell-autonomous manner, involving mutp53 inhibition of the p63/DICER/miRNA pathway, by upregulating the Rab-coupling protein (RCP) and the diacylglycerol kinase-α (DGKα)-dependent endosomal recycling of integrins and receptor tyrosine kinases [116,117,118].